Scar Therapeutics - A Pipeline Analysis Report
- Published: Aug 2018
- Pages: 79
- SKU: IRTNTR23018
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
This pipeline analysis report provides detailed insights into the clinical trials landscape of the drug development for scar therapeutics including molecules at pre-clinical and discovery stage. The report also offers comprehensive information about the therapeutic assessment of the pipeline molecules based on various segmentations such as therapy, route of administration, and target.
Overview of the drug development pipeline for scar therapeutics
It has been observed that scars are the changes in the physical architecture of the skin. A scar occurs on the skin due to damage in the deeper layer of the skin, the dermis. Scars can also occur due to the healing process of skin tissues, and the severity of the scar depends upon the nature of the wound damage. In dermatology, a scar is the area of tissue that replaces the normal skin after an injury. The skin is in direct contact with the environment, and there are high chances of developing sensations and irritations. However, the appearance of scars differs from person to person, depending on the skin type, the location affected, and the type of injury. The different types of scars namely are keloid scars, hypertrophic scars, contracture scars, and acne scars. The most efficient approach for the treatment of scar tissue is considered to be monotherapy.
According to this pipeline analysis report, most of the drug molecules in the pipeline are being developed for the treatment of keloid scars. Our market research analysts have also identified that most of these molecules are in the pre-clinical development stage and a considerable number of molecules have been discontinued from development.
Pipeline analysis report on drug development for scar therapeutics: Companies covered
This pipeline analysis report provides a detailed analysis of the companies that are involved in the development of drug molecules for the treatment of different types of scars. In addition to providing information on the various stages of molecules developed by companies for different indications, this pipeline analysis report also provides information about the drug molecules discontinued by companies.
Some of the companies covered in this pipeline analysis report are
- Adisave
- BirchBioMed
- Bonti
- OliX Pharmaceuticals
- Pharmaxis
Therapeutic assessment of the drug development pipeline for scar therapeutics by route of administration
- Intradermal
- Topical
- Intradermal and topical
- Intramuscular
- Oral
- Parenteral
- Subcutaneous
- Subcutaneous and intradermal
- Unknown
The intradermal route of administration (ROA) involves the administration of the drug into the dermis, just below the epidermis with the use of injection, which will have a more direct effect on the target cells. In the topical technique, the drug molecules are applied to a particular place on or in the body
Therapeutic assessment of the drug development pipeline for scar therapeutics by therapy
- Monotherapy
- Unspecified
According to this pipeline analysis report, most of the molecules that are currently in the drug development pipeline for treatment of scars are being developed as monotherapy drugs and most of these molecules are in the pre-clinical stage of development.
Key questions answered in the report include
- What are the drug molecules in the various development stages for scar therapeutics?
- What are the companies that are currently involved in the development of drug molecules for scar therapeutics?
- Insight into discontinued/inactive molecules with appropriate reasoning?
- What are the major regulatory authorities approving drugs in various regions?
- Detailed profiling of each active molecule
Technavio also offers customization on reports based on specific client requirement.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
PART 05: MAJOR REGULATORY AUTHORITIES
- US
- Europe
- China
PART 06: PIPELINE LANDSCAPE
PART 07: COMPARATIVE ANALYSIS
- Discovery stage molecules
- Pre-clinical stage molecules
- Inactive and discontinued molecules
PART 08: INDICATION ANALYSIS
PART 09: THERAPEUTIC ASSESSMENT (THERAPY BASED)
PART 10: THERAPEUTIC ASSESSMENT (ROA BASED)
PART 11: THERAPEUTIC ASSESSMENT BY TARGET
PART 12: KEY COMPANIES
- Active companies: Category and parameters
PART 13: APPENDIX
- List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
